| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |